CannXtions Practitioner Pathways & Quality Framework
As the Australian market for unregistered therapies experiences rapid, long-term growth, ensuring clinical confidence requires a rigorous quality framework. With thousands of products available via the special access pathway, navigating patient care demands robust chemical analysis (such as comprehensive Certificates of Analysis evaluating active compound bioavailability and limits of detection) alongside dependable continuity of supply logistics to prevent treatment interruptions. Supported by our distribution partner Novachem, the CannXtions QUALITY Medicine Guide underpins every pathway to empower your practice with verified, high-standard therapeutic options.
Referral Pathway
Refer your patients to a safe pair of hands while staying informed on their ongoing progress. Our expert collaborative clinic team manages complex endocannabinoid system (ECS) regulation, high-risk medicine tapering, and administration logistics, allowing you to focus on general patient care in collaboration with an expert prescriber.
Prescribing with Peer Support
Step into prescribing with structured peer mentoring and clinical support. Designed for practitioners building confidence in ECS medicine, this option combines 1-on-1 mentoring from Dr. Gibb or one of our experienced partners, with step-by-step guidance on TGA documentation (SAS B / AP applications), dosing strategy ("start low, go slow"), and quality analysis interpretation.
Prescribe with Confidence
For experienced prescribers seeking to streamline their workflow and maintain full clinical autonomy in their own practice. Gain direct access to all you need to consider when choosing which medicine in one place. View an overall score, or the independent pillars of quality that you consider most valuable
Find full Certificates of Analysis (CoA), sponsor research data, and real time stock updates for quality-verified products. See which medicines experienced prescribers have selected for specific indications.